Proportion of patients who may potentially avoid liver biopsy using the simple non-invasive tests to exclude advanced fibrosis
| Cut-off | Patients avoiding liver biopsy* | False negative result | |
| AST/ALT | <0.8 | 100/145 (69%) | 7 (7%) |
| BARD score | <2 | 55/145 (38%) | 3 (5%) |
| FIB-4 score | <1.30 | 90/145 (62%) | 4 (5%) |
| NAFLD fibrosis score | <−1.455 | 75/145 (52%) | 6 (8%) |
↵* Patients with a value below the cut-off.
ALT, alanine aminotransferase; AST, aspartate aminotransferase; NAFLD, non-alcoholic fatty liver disease.